Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Laboratory And Mouse Studies Show Targeted Drug Blocks The Growth Of Breast Cancer Cells That Spread To The Brain
http://www.medicalnewstoday.com/articles/116690.php
Using laboratory and mouse models of human breast cancer, researchers have found that a small molecule capable of targeting specific proteins on the surface of breast cancer cells can inhibit the growth of breast cancer cells that migrate to the brain.
----------------------------------------------
** CANCER / ONCOLOGY News **
Vote Now For The 2008 Beacons Of Hope Awards, Lymphoma Association, UK
http://www.medicalnewstoday.com/articles/116789.php
The Lymphoma Association, the only specialist UK charity that provides medical information and support to lymphatic cancer patients, their families and friends, is calling for nominations for their annual Beacons of Hope Awards.
Journal Of The National Cancer Institute July 29
http://www.medicalnewstoday.com/articles/116735.php
<b>The Same Dose of Anthracycline Is Not Safe for Everyone</b>Not all patients can tolerate the currently recommended cumulative dose of epirubicin. New models can help physicians calculate the epirubicin dose associated with a 5 percent risk of cardiotoxicity for individual patients.
Despite Hazards, 1/5 Of British Adult Survivors Of Childhood Cancer Are Smokers
http://www.medicalnewstoday.com/articles/116731.php
One-fifth of British adult survivors of childhood cancers are current smokers, and nearly a third have been regular smokers at some point in their lives, according to a study in the July 29 online issue of the <i>Journal of the National Cancer Institute</i>.
Sunitinib Malate Is Active Against Human Urothelial Carcinoma And Enhances The Activity Of Cisplatin In A Preclinical Model
http://www.medicalnewstoday.com/articles/116724.php
UroToday.com - Standard front-line cisplatin-based combination chemotherapy for metastatic transitional cell carcinoma (TCC) with either MVAC (methotrexate, vinblastine, doxorubicin, cisplatin) or GC (gemcitabine, cisplatin) yields a median survival of approximately 15 months.
Randomized Phase III Trial Comparing Retroperitoneal Lymph Node Dissection With One Course Of Bleomycin And Etoposide Plus Cisplatin Chemotherapy
http://www.medicalnewstoday.com/articles/116713.php
UroToday.com - In the June 20, 2008 issue of the<i> Journal of Clinical Oncology</i>, Dr. Peter Albers and colleagues presented the results of a large randomized German trial in men with stage I nonseminomatous germ cell tumors (NSGCT).
Seattle's Swedish Cancer Institute First In U.S. To Treat Cancer Patient With Elekta VMAT
http://www.medicalnewstoday.com/articles/116708.php
A patient with pancreatic cancer recently became the first person in the United States to receive treatment using Elekta VMAT (Volumetric intensity Modulated Arc Therapy) at Seattle's Swedish Cancer Institute.
Giving 'Meaning' To Measurement In Prostate Cancer
http://www.medicalnewstoday.com/articles/116640.php
Can scores of patient-reported outcome (PRO) measures be made more meaningful to patients and physicians? For years patients, physicians, and policy makers have questioned the usefulness of scores generated by PRO measures.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
No news for this category today.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
Vote Now For The 2008 Beacons Of Hope Awards, Lymphoma Association, UK
http://www.medicalnewstoday.com/articles/116789.php
The Lymphoma Association, the only specialist UK charity that provides medical information and support to lymphatic cancer patients, their families and friends, is calling for nominations for their annual Beacons of Hope Awards.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
New Data On Nymox BPH Drug To Be Presented At American Urological Association Meeting In Monterey October 26-30
http://www.medicalnewstoday.com/articles/116774.php
Nymox Pharmaceutical Corporation (NASDAQ: NYMX) today announced that new clinical trial data concerning the safety and efficacy of the Company's NX-1207 for benign prostatic hyperplasia (BPH) will be presented at the Annual Meeting of the Western Section of the American Urological Association Meeting being held in Monterey, CA from October 26 to 30, 2008.
Oestrogen And Benign Prostatic Hyperplasia: Effects On Stromal Cell Proliferation And Local Formation From Androgen
http://www.medicalnewstoday.com/articles/116726.php
UroToday.com - Previous animal studies suggested a role for estrogens in the pathogenesis of benign prostatic hyperplasia (BPH) 1,2. Estrogens interact with two forms of estrogen receptor (ER), ERα and ERβ.
Pathologic T2 Stage Subgroups And Recurrence-Free Survival After Radical Prostatectomy
http://www.medicalnewstoday.com/articles/116722.php
UroToday.com - In the online version of <i>Urology</i>, Dr. James McKiernan and a group of investigators at Columbia University reported that while clinical subgroups of stage cT2 prostate cancer (CaP) have prognostic significance, pathologic subgroups of stage pT2 do not.
Performance Of Prostate Specific Antigen For Predicting Prostate Cancer Is Maintained After A Prior Negative Prostate Biopsy
http://www.medicalnewstoday.com/articles/116721.php
UroToday.com - In the August 2008 issue of the <i>Journal of Urology</i>, Dr. Ian Thompson and colleagues explored the performance characteristics of PSA after a previous negative prostate biopsy.
Prostate Cancer Detection Rate In Patients With Repeated Extended 21-Sample Needle Biopsy
http://www.medicalnewstoday.com/articles/116719.php
UroToday.com - In an article by a group of French investigators that appears in the online version of <i>European Urology</i>, they examine the issue of whether one negative extended prostate cancer (CaP) biopsy should reassure patients that they do not have CaP.
New Treatment For Advanced Prostate Cancer
http://www.medicalnewstoday.com/articles/116641.php
Researchers at the University of Adelaide have developed a novel approach to treating advanced prostate cancer that could be more effective with fewer side effects.<a href="http://www.health.
Giving 'Meaning' To Measurement In Prostate Cancer
http://www.medicalnewstoday.com/articles/116640.php
Can scores of patient-reported outcome (PRO) measures be made more meaningful to patients and physicians? For years patients, physicians, and policy makers have questioned the usefulness of scores generated by PRO measures.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment